British Columbia Investment Management Corp Vertex Pharmaceuticals Inc Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 43,058 shares of VRTX stock, worth $20.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

43,058

Previous 49,474 12.97%

Holding current value

$20.2 Million

Previous $23.2 Million 13.64%

% of portfolio

0.12%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $2.95 Million - $3.25 Million	-6,416 Reduced 12.97%	43,058 $20 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $7.31 Million - $9.03 Million	18,605 Added 60.27%	49,474 $23.2 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $472,105 - $516,560	1,158 Added 3.9%	30,869 $12.9 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $2.16 Million - $2.58 Million	6,290 Added 26.86%	29,711 $12.1 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $64,930 - $69,592	192 Added 0.83%	23,421 $8.14 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $83,006 - $92,904	264 Added 1.15%	23,229 $8.17 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $62,877 - $71,728	222 Added 0.98%	22,965 $7.24 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $730,974 - $822,345	-2,558 Reduced 10.11%	22,743 $6.57 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $1.17 Million - $1.31 Million	-4,278 Reduced 14.46%	25,301 $7.33 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $2.27 Million - $2.83 Million	-9,673 Reduced 24.64%	29,579 $8.34 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $1.41 Million - $1.66 Million	-6,360 Reduced 13.94%	39,252 $10.2 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $413,672 - $522,202	-2,337 Reduced 4.87%	45,612 $10 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $23,762 - $26,591	-131 Reduced 0.27%	47,949 $8.7 Million
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $1.02 Million - $1.2 Million	5,433 Added 12.74%	48,080 $9.69 Million
Q1 2021 Apr 30, 2021	SELL	$207.02 - $241.31 $297,073 - $346,279	-1,435 Reduced 3.26%	42,647 $9.16 Million
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $194,589 - $259,524	-940 Reduced 2.09%	44,082 $10.4 Million
Q3 2020 Nov 10, 2020	BUY	$255.65 - $303.1 $888,383 - $1.05 Million	3,475 Added 8.36%	45,022 $12.3 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $3.02 Million - $3.96 Million	13,377 Added 47.49%	41,547 $12.1 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $6.49 Million - $8.05 Million	-32,483 Reduced 53.56%	28,170 $6.7 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $7.6 Million - $10.2 Million	-45,603 Reduced 42.92%	60,653 $13.3 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $2.08 Million - $2.34 Million	-12,529 Reduced 10.55%	106,256 $18 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $936,960 - $1.08 Million	5,692 Added 5.03%	118,785 $21.8 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $586,317 - $697,220	3,581 Added 3.27%	113,093 $20.8 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $3.87 Million - $4.89 Million	25,443 Added 30.26%	109,512 $18.1 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $4.42 Million - $5.08 Million	-26,372 Reduced 23.88%	84,069 $16.2 Million
Q2 2018 Aug 09, 2018	SELL	$145.72 - $169.96 $3.68 Million - $4.3 Million	-25,272 Reduced 18.62%	110,441 $18.8 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $1.48 Million - $1.73 Million	-9,790 Reduced 6.73%	135,713 $22.1 Million
Q4 2017 Feb 20, 2018	SELL	$137.28 - $155.55 $7.81 Million - $8.85 Million	-56,869 Reduced 28.1%	145,503 $21.8 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $30 Million - $32.8 Million	202,372	202,372 $30.8 Million

Others Institutions Holding VRTX

# of Institutions

1,726

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Vertex Pharmaceuticals Inc Transaction History